In silico identification and biological evaluation of a selective MAP4K4 inhibitor against pancreatic cancer

Inhibiting a specific target in cancer cells and reducing unwanted side effects has become a promising strategy in pancreatic cancer treatment. MAP4K4 is associated with pancreatic cancer development and correlates with poor clinical outcomes. By phosphorylating MKK4, proteins associated with cell a...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Chao-Di, Chao, Min-Wu, Lee, Hsueh-Yun, Liu, Yi-Ting, Tu, Huang-Ju, Lien, Ssu-Ting, Lin, Tony Eight, Sung, Tzu-Ying, Yen, Shih-Chung, Huang, Sing-Han, Hsu, Kai-Cheng, Pan, Shiow-Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873280/
https://www.ncbi.nlm.nih.gov/pubmed/36683274
http://dx.doi.org/10.1080/14756366.2023.2166039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873280/
https://www.ncbi.nlm.nih.gov/pubmed/36683274
http://dx.doi.org/10.1080/14756366.2023.2166039

Ejemplares similares